Navigation Links
Data from Rexahn Pharmaceuticals' Phase I Trial of RX-0201,(Archexin) to Be Presented at the 43rd American Society of Clinical,Oncology Annual Meeting in Chicago

ROCKVILLE, Md.--(BUSINESS WIRE)--May 30, 2007 - Rexahn Pharmaceuticals, Inc. (OTC BB:RXHN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs, today announced that Dr. John Marshall, Principal Investigator of Phase I clinical trial of the Company's lead cancer compound RX-0201 (Archexin), will present results of the clinical study at the 43rd American Society of Clinical Oncology (ASCO) Annual Meeting, to be held June 1-5, 2007 at McCormick Place in Chicago, Illinois.

The presentation, entitled, "A Phase I Trial of RX-0201 (AKT anti-sense) in Patients with Advanced Cancer," is scheduled for Sunday, June 3, 2007 at 9am Central Time.

About Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals is a biopharmaceutical company leveraging its unique technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn's compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain quality of life through therapy. For Additional information about Rexahn visit www.rexahn.com.

Contact

Rexahn Pharmaceuticals, Inc.
Amanda Sawney, 240-268-5300 x300


'"/>




Page: 1

Related medicine technology :

1. Faust Pharmaceuticals Phase IIa Results for Parkinsons Disease Presented at International Congress of Parkinsons Disease and Movement Disorders
2. VGX Pharmaceuticals Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
3. Aeolus Pharmaceuticals AEOL 10113 May Play an Important Role Regulating the Oxidative Damage Induced by Ionizing Radiation
4. Aeolus Pharmaceuticals AEOL 10113 Demonstrates Potential as a Protector of Healthy Normal Cells from Cancer Radiation Therapy
5. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
6. ACADIA Pharmaceuticals Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone

Post Your Comments:
(Date:11/30/2009)... 30 Sanofi-aventis U.S. ...ing agreement with Intelliject, Inc. for a novel e...nt of allergic reactions (anaphylaxis) in North Am... have this opportunity to offer this innovative de...t risk of this life-threatening allergic reaction ...
(Date:11/29/2009)...re/ -- Radiologists can accurately diagnose acute ...f a handheld device or mobile phone equipped with ...oday at the annual meeting of the Radiological Soc...to improve the speed and accuracy of medical diagn...ifferent consulting physicians," said the study,s ...
(Date:11/29/2009)...wire/ -- At the 95th Scientific Assembly and Annu...erica (RSNA), "Images, my way" will resonate throu...ember 29 to December 3 at McCormick Place (Booth #...cago. This year,s booth displays and demonstration...ustomers to generate, process, read, and share cli...
Breaking Medicine Technology:Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America 2Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America 3Smart Phones Allow Quick Diagnosis of Acute Appendicitis 2Smart Phones Allow Quick Diagnosis of Acute Appendicitis 3Siemens Delivers Images per the Customer's Request - 'Images My Way' 2Siemens Delivers Images per the Customer's Request - 'Images My Way' 3Siemens Delivers Images per the Customer's Request - 'Images My Way' 4Siemens Delivers Images per the Customer's Request - 'Images My Way' 5Siemens Delivers Images per the Customer's Request - 'Images My Way' 6Siemens Delivers Images per the Customer's Request - 'Images My Way' 7Siemens Delivers Images per the Customer's Request - 'Images My Way' 8Siemens Delivers Images per the Customer's Request - 'Images My Way' 9Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 1Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 2Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 3Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 4Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 5Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 6Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 7Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 8Lexi Comp ONLINE 26amp 3B 238482 3B for Oral Surgery 53806 1Lexi Comp ONLINE 26amp 3B 238482 3B for Oral Surgery 53806 2Lexi Comp ONLINE 26amp 3B 238482 3B for Oral Surgery 53806 3SDSU 26apos 3Bs Process Improvement Programs Help Businesses Achieve Bottom Line Results 53801 1SDSU 26apos 3Bs Process Improvement Programs Help Businesses Achieve Bottom Line Results 53801 2SDSU 26apos 3Bs Process Improvement Programs Help Businesses Achieve Bottom Line Results 53801 3
...ax Will Remain the NSTEMI Market Share Leader Thro...Resources , , WALTHAM, Mass., Feb. 25 Decision R...advisory firms for pharmaceutical and healthcare i...of mortality at 30 days is the attribute that most...cisions in non-ST elevation myocardial infarction ...
...res and infections of the bone are among most seri...Severe musculoskeletal conditions in children incl... as slipped epiphysis, and elbow fractures. These ...mplications if children are not treated properly a...leased today at the 2009 Annual Meeting of the Am...
Other Medicine Technology:Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI 2Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI 3Children and Orthopaedic Surgical Emergencies 2Children and Orthopaedic Surgical Emergencies 3
(Date:11/30/2009)... tumor without disturbing normal tissue presents c...can be invasive and harsh. , Researchers at Duke... might deliver the right therapy directly to tumor...specifically bind to living tumor tissue. , They...h liver cancer until they found the best molecule ...
(Date:11/30/2009)...e our patients, their caregivers, and our communit...omen,s Health of North America in Florida will off...s available to all individuals (male and female) 4...te a convenient LOCATION near you or call 1-877-...ber 30, 2009 -- According to the most recent Cente...
(Date:11/30/2009)...n the rise in the developing world but falling in ... stop smoking cigarette, but the recent report say...elp people quit smoking cigarette. http://www.El...help heavy smokers cut down on their cigarette whi...os Angeles, CA (PRWEB) November 30, 2009 -- The i...
(Date:11/30/2009)...ember 30 Simbionix USA Corporation...ion systems, in collaboration,with GORE Medical Pr...io(TM),workshop for the first time at the upcoming...e Simbionix PROcedure Rehearsal Studio(TM) is the ...ns to create practice scenarios based on their,pat...
(Date:11/30/2009)...nts who undergo abdominal/pelvic computed tomograp...onal image acquisition resulting in excess, avoida...nted today at the annual meeting of the Radiologic... responsibility of all physicians who work with io...ow as reasonably achievable without compromising t...
Breaking Medicine News(10 mins):Health News:First live targeting of tumors with RNA-based technology 2Health News:First live targeting of tumors with RNA-based technology 3Health News:2009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women's Health of North America in Florida 2Health News:2009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women's Health of North America in Florida 3Health News:Stop Smoking Cigarette with Electronic Cigarette (E-Cig), Today You Can Quit Smoking Too 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Unindicated CT series result in unnecessary radiation exposure for patients 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 3
...apply to males of other ethnicities, researchers s...inking increases the risk of stroke in Chinese men...4,338 men who were 40 and older and had no history...okes and 1,848 fatal strokes. After they adjusted ...
...view finds that implantable cardioverter defibrill...th for adults with left ventricular systolic dysfu...andomized controlled trials that reported on morta... dysfunction by 20 percent. This reduction came mo...
...toms of anxiety, depression once back home , SUNDA...symptom of post-traumatic stress disorder (PTSD) w...the U.S. Air Force deployed during the Iraq War, s...cent officers) were deployed at least once since M...
... Scientists know that information travels between .... For the first time, researchers have found that ...n the signal up or down with the right stimulation...fferent parts of the brain do not communicate corr...
...ering anthocyanin molecules could lead to new trea...ews) -- Compounds called anthocyanins, which give ...tables, may help protect against colon cancer, an ...ntly slow the growth of colon cancer cells. The te...
...der white men who are better able to cope with str...lesterol than men who are more hostile or socially...5th Annual Convention of the American Psychologica...from 716 men who participated in the Normative Agi...
Other Medicine News:Health News:Heavy Drinking Boosts Stroke Risk for Chinese Men 2Health News:Work-Family Conflict Dogs Air Force Women After Deployment 2Health News:Brain cells work differently than previously thought 2Health News:Ability to cope with stress can increase 'good' cholesterol in older white men, study finds 2
Visulas Yag II plus
...g color vision abnormalities and testing color dis...pplied to many psychological and industrial color ...ntaining a total of 85 removable color reference c...e and are numbered on the reverse side. Color visi...
...orth-Munsell 100 Hue Test. It is intended for scre...of a color vision defect. It provides a benchmark ...inguishing color differences in certain tasks. The...nsell notations, plus a neutral (N 5) cap. The cap...
Magnetic Farnsworth D15 Kit
Medicine Products: